Elmiron and Maculopathy: Increased Risk of Ocular Complications in Long-Term, High-Dose Elmiron Use

September 8, 2021

Xeljanz: FDA Warnings Updated: There are Higher Rates of Blood Clots and Deaths for Both Doses of Xeljanz, Now

September 1, 2021

Tasigna Lawsuits Federal Court MDL Order Issued in August 2021 After July 2021 JPML Hearing

August 20, 2021

Research Tools to Find Safety and Warnings Information for Possible Drug Injury Cases

August 10, 2021

Some Current Drug Injury Lawsuits Being Filed Against Pharmaceutical Companies as of August 2021

August 5, 2021

Invokana, Farxiga, Jardiance, Other SGLT2 Inhibitors Associated With Retinal Vein Occlusion

July 16, 2021

Possible FDA Advisory Committee Meeting for Xeljanz, Rinvoq, and Other Janus Kinase (JAK) Inhibitors

July 6, 2021

Products Recall: Philips Bi-Level PAP, CPAP, and Mechanical Ventilator Devices Using PE-PUR Sound Abatement Foam

June 23, 2021

Tasigna Drug Injury Lawsuits Consolidated for Pretrial Proceedings: June 2021 Update

June 16, 2021

Beovu Vision Loss Side Effects Continue to Plague Novartis, Ending 3 Key Clinical Trials in May 2021

June 1, 2021